Ultragenyx Pharmaceutical Inc. <RARE.O>: Citigroup cuts target price to $28 from $58
RARE•Related News
Buckle August net sales rise 3.6% to $123.5 million
BKE•
Invivyd grants new-hire inducement stock options for 255,000 shares at $0.88 each
IVVD•
Honeywell to present at Morgan Stanley Laguna investor conference
HON•
Campbell's forecasts annual sales below estimates on weak consumer spending
CPB•
Ultragenyx Pharmaceutical Inc. <RARE.O>: Leerink Partners cuts target price to $33 from $60
RARE•